田野崎 隆二

Medicine & Life Sciences

1. Hematopoietic Stem Cell Transplantation 100%
2. Adult T Cell Leukemia Lymphoma 61%
3. Stem Cell Transplantation 59%
4. Graft vs Host Disease 43%
5. Allogeneic Cells 32%
6. Tissue Donors 26%
7. Transplants 24%
8. Busulfan 22%
9. Peripheral Blood Stem Cell Transplantation 21%
10. Transplantation 19%
11. Cell Transplantation 16%
12. Antilymphocyte Serum 16%
13. Human T-lymphotropic virus 1 16%
14. Peripheral Blood Stem Cells 16%
15. Myelodysplastic Syndromes 16%
16. Chimerism 13%
17. Bone Marrow Transplantation 13%
18. Hematopoietic Stem Cells 13%
19. Bone Marrow 12%
20. Cladribine 12%
21. T-Lymphocytes 12%
22. Cytomegalovirus 12%
23. Homologous Transplantation 12%
24. Stem Cells 12%
25. Unrelated Donors 11%
26. Leukemia 11%
27. Acute Myeloid Leukemia 11%
28. Granulocyte Colony-Stimulating Factor 10%
29. Recurrence 10%
30. Lymphoma 10%
31. Survival 10%
32. Cytotoxic T-Lymphocytes 10%
33. Retrospective Studies 9%
34. Dendritic Cells 9%
35. Japan 9%
36. Mortality 9%
37. Hematologic Neoplasms 9%
38. fludarabine 8%
39. Siblings 8%
40. Therapeutics 8%
41. Immunotherapy 8%
42. Drug Therapy 8%
43. Non-Hodgkin's Lymphoma 7%
44. Neoplasms 7%
45. Prednisolone 6%
46. Fetal Blood 6%
47. Infections 6%
48. Whole-Body Irradiation 6%
49. Cyclophosphamide 6%
50. Incidence 5%